Preview

Torrent Pharma

Powerful Essays
Open Document
Open Document
39474 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Torrent Pharma
Creating value, driving growth
3 7 th A N N U A L R E P O R T 2 0 0 9 - 2 0 1 0

37th ANNUAL REPORT 2009-10

Torrent Pharmaceuticals Limited

2

N TE CO N

TS

Corporate Information 02 Notice 03 Directors’ Report 06 Report on Corporate Governance 14 Auditors’ Report 24 Audited Financial Statements 28 Management Discussion and Analysis 55 Consolidated Financial Statements 66

37th ANNUAL REPORT 2009-10

3

CORPORATE INFORMATION
DIRECTORS
Sudhir Mehta
Chairman

REGISTERED OFFICE
Torrent House,

Markand Bhatt S. H. Bhojani Dr. Prasanna Chandra Kiran Karnik Sanjay Lalbhai Dr. C. Dutt
Director (Research & Development)

Off Ashram Road, Ahmedabad – 380 009 Telephone : 079-26585090 Fax : 079-26582100

MANUFACTURING FACILITIES
1) 2) Village Indrad, Taluka Kadi, Dist. Mehsana (Gujarat) Village Bhud, Baddi, Teh. Nalagarh, Dist. Solan (Himachal Pradesh)

Samir Mehta

Managing Director

AUDIT COMMITTEE
Dr. Prasanna Chandra
Chairman

SIKKIM PROJECT SITE
32 No. Middle Camp, NH - 31A, East District, Gangtok (Sikkim)

S. H. Bhojani Kiran Karnik

RESEARCH & DEVELOPMENT FACILITY
Village Bhat, Dist. Gandhinagar (Gujarat)

SECURITIES TRANSFER & INVESTORS’ GRIEVANCE COMMITTEE
Sudhir Mehta
Chairman

WEBSITE www.torrentpharma.com REGISTRARS & TRANSFER AGENTS
Karvy Computershare Private Ltd., Unit : Torrent Pharmaceuticals Limited, Plot No. 17 to 24, Vittalrao Nagar, Madhapur, Hyderabad 500 081 Telephone : 040-44655000, Fax : 040-23420814 Email : einward.ris@karvy.com

Markand Bhatt Samir Mehta

VP (LEGAL) & COMPANY SECRETARY
Mahesh Agrawal

AUDITORS
C.C. Chokshi & Co.
Chartered Accountants (Registration No. 101876W)

INVESTOR SERVICES E-MAIL ID investorservices@torrentpharma.com 2

NOTICE
NOTICE IS HEREBY GIVEN THAT THE THIRTY SEVENTH ANNUAL GENERAL MEETING OF THE MEMBERS OF TORRENT PHARMACEUTICALS LIMITED will be held on Friday, 30th July, 2010 at 09:30 AM at J. B. Auditorium, Torrent AMA Center, Ground

You May Also Find These Documents Helpful

  • Powerful Essays

    CONTENTS Performance Analysis Chairman’s and Chief Executive Officer and Managing Director’s Report Five Year Financial Statistics Executive Committee Corporate Governance Statement…

    • 57541 Words
    • 521 Pages
    Powerful Essays
  • Powerful Essays

    Pandey, Ashok, Poonam Nigam, Carlos R. Socool, Vanete T. Soccol, Dalel Singh, and Radjiskumar Mohan.…

    • 2769 Words
    • 12 Pages
    Powerful Essays
  • Powerful Essays

    David Jones Annual Report 2010

    • 27316 Words
    • 110 Pages

    Performance Analysis Chairman’s Report Chief Executive Officer’s Report Five Year Financial Statistics Board of Directors Management Committee Corporate Governance Statement Occupational Health & Safety People Community Environment Directors’ Report Remuneration Report Financial Statements Directors’ Declaration Auditor’s Independent Declaration Independent Audit Report Shareholder Information Corporate Directory…

    • 27316 Words
    • 110 Pages
    Powerful Essays
  • Satisfactory Essays

    Christina Resume 1

    • 156 Words
    • 2 Pages

    7 0 8 T i d m o r e S t, G a d s d e n, A L 3 5 9 0 1…

    • 156 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Blah

    • 65241 Words
    • 261 Pages

    33 Board of Directors 37 Executive management 41 Corporate information 42 Notice 45 Explanatory statement 51 Particulars of Directors seeking appointment/reappointment 53 Directors’ report 62 Annexure to the Directors’ report 67 Management discussion and analysis report 74 Report on corporate governance for 2011/12 91 Auditors’ certificate…

    • 65241 Words
    • 261 Pages
    Good Essays
  • Good Essays

    This leaflet is written by the manufacturing pharmaceutical companies and it important that all licensed products have leaflets available.…

    • 796 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Tesco Annual Report

    • 26085 Words
    • 105 Pages

    Financial highlights Operating and financial review Directors’ report Corporate governance Report of the directors on remuneration Statement of directors’ responsibilities Independent auditors’ report Group profit and loss account Statement of total recognised gains and losses Reconciliation of movements in shareholders’ funds…

    • 26085 Words
    • 105 Pages
    Powerful Essays
  • Powerful Essays

    Report

    • 17055 Words
    • 69 Pages

    CONTENTS Corporate Information Chairman's Statement Corporate Governance Statement Directors' Report Auditor's Independence Declaration Financial Report for the year ended 30 June 2011 Consolidated Income Statement Consolidated Statement of Comprehensive Income Consolidated Statement of Financial Position Consolidated Statement of Changes in Equity Consolidated Statement of Cash Flows Notes to the Financial Statements Directors' Declaration Independent Auditor's Report ASX Additional Information…

    • 17055 Words
    • 69 Pages
    Powerful Essays
  • Satisfactory Essays

    Core competencies lead to the development of core products. Core products are not directly sold to end users; rather, they are used to build a larger number of end-user products. For example, motors are a core product that can be used in wide array of end products. The business units of the corporation each tap into the relatively few core products to develop a larger number of end user products based on the core product technology.…

    • 2850 Words
    • 12 Pages
    Satisfactory Essays
  • Good Essays

    Pharma Update 08 Nov 2014

    • 766 Words
    • 3 Pages

    The USFDA has reverted its tentative approvals granting Ranbaxy six-months sales exclusivity of the generic versions of Roche's anti-viral drug Valcyte and AstraZeneca's heartburn pill Nexium. Ranbaxy had first-to-file status on both these drugs and it was expected to earn USD 60 million and USD 180 million from the generic versions of Valcyte and Nexium respectively in the exclusive sale period. The USFDA said that its original decision of granting tentative approvals were erroneous because of the compliance status of the facilities mentioned in the ANDAs (Abbreviated New Drug Application) filed by Ranbaxy, as a result of which in FDA's view, Ranbaxy had forfeited its eligibility for 180-day exclusivity for its ANDA for Valcyte. The news could hit the shares of Ranbaxy and Sun Pharma, already under CCI's scanner for the $4 billion M&A deal, the decision for which is expected this month. Earlier in the week,Ranbaxy had received approval from the USFDA to manufacture and market Fenofibrate capsules, used for lowering high cholesterol and triglyceride levels in the blood.…

    • 766 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    The variety of their pharmaceutical products is large which covers cardiovascular diseases, central nervous system diseases, genito-urinary system diseases, upper and lower respiratory system diseases.......etc.…

    • 5543 Words
    • 23 Pages
    Powerful Essays
  • Best Essays

    Corporate Governance Tesco

    • 2252 Words
    • 7 Pages

    Tesco PLC Annual Report and Financial Statements 2014: Board of Directors. (2014). 1st ed. [ebook] Available at: http://www.tescoplc.com/assets/files/cms/Annual_report_2014/Corporate_governance.pdf [Accessed 26 Mar. 2015].…

    • 2252 Words
    • 7 Pages
    Best Essays
  • Satisfactory Essays

    Keti Ltd Profile

    • 2228 Words
    • 9 Pages

    C/o. Yash Plaza (Flat System), Block No. 3, Kishore Nagar, Dist : Nanded ( M.S.)…

    • 2228 Words
    • 9 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Ganapathy Dr 1. V. Ramanuja Rao Dr K. Ghavami Mr K. Ravindran ,,`; / J J. h m '. ; a 1:? .…

    • 25668 Words
    • 157 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Sugar Manufacturing

    • 5508 Words
    • 23 Pages

    Manjari (Bk), Pune, Maharashtra 412 307 Telephone: (020) 26902100, 26902343/7/6, Fax (020) 26902244 Web Site: www.vsisugar.com…

    • 5508 Words
    • 23 Pages
    Satisfactory Essays